Richard J. Daly, President and CEO of Catalyst Pharmaceuticals, Inc. ($CPRX), sold shares on the open market twice in the last year, totaling $2.2 million. His most recent sale occurred on August 26, 2025. These sales rank 3,297th among 11,678 individual insiders in our database, where the average is $8.6 million across about 6.4 transactions. Daly made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 5, 2026 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | M | Restricted Stock Units | 42105 | $0.00 | 2,618,539.0000 | 127,201,954 | 1.58% | 0.03% |
| Jan. 5, 2026 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | F | Common Stock, par value $0.001 per share | 10577 | $0.00 | 271,266.0000 | 127,201,954 | 3.75% | 0.01% |
| Jan. 5, 2026 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | M | Common Stock, par value $0.001 per share | 42105 | $0.00 | 281,843.0000 | 127,201,954 | 17.56% | 0.03% |
| Dec. 29, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | M | Common Stock, par value $0.001 per share | 1334 | $0.00 | 240,262.0000 | 127,201,954 | 0.56% | 0.00% |
| Dec. 29, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | M | Restricted Stock Units | 1334 | $0.00 | 2,660,644.0000 | 127,201,954 | 0.05% | 0.00% |
| Dec. 29, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | F | Common Stock, par value $0.001 per share | 524 | $0.00 | 239,738.0000 | 127,201,954 | 0.22% | 0.00% |
| Nov. 21, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | F | Common Stock, par value $0.001 per share | 7872 | $0.00 | 238,928.0000 | 127,201,954 | 3.19% | 0.01% |
| Nov. 21, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | M | Restricted Stock Units | 20006 | $0.00 | 2,661,978.0000 | 127,201,954 | 0.75% | 0.02% |
| Nov. 20, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | A | Restricted Stock Units | 115283 | $0.00 | 2,681,984.0000 | 127,201,954 | 4.49% | 0.09% |
| Nov. 20, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | A | Options to purchase common stock | 381948 | $0.00 | 2,546,695.0000 | 127,201,954 | 17.64% | 0.30% |
| Nov. 21, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | M | Common Stock, par value $0.001 per share | 20006 | $0.00 | 246,800.0000 | 127,201,954 | 8.82% | 0.02% |
| Aug. 26, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | S | Common stock, par value $0.001 per share | 22970 | $20.62 | 226,794.0000 | 124,943,603 | 9.20% | 0.02% |
| Aug. 26, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | M | Common stock, par value $0.001 per share | 50000 | $2.24 | 249,764.0000 | 124,943,603 | 25.03% | 0.04% |
| Aug. 26, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | M | Options to purchase common stock | 50000 | $0.00 | 2,184,753.0000 | 124,943,603 | 2.24% | 0.04% |
| May 30, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | S | Common stock, par value $0.001 per share | 70000 | $24.86 | 199,764.0000 | 124,943,603 | 53.94% | 0.06% |
| Feb. 14, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | M | Common Stock, par value $0.001 per share | 4000 | $0.00 | 271,338.0000 | 124,943,603 | 1.50% | 0.00% |
| Feb. 14, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | M | Restricted Stock Units | 4000 | $0.00 | 2,234,753.0000 | 124,943,603 | 0.18% | 0.00% |
| Feb. 14, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | F | Common Stock, par value $0.001 per share | 1574 | $0.00 | 269,764.0000 | 124,943,603 | 0.58% | 0.00% |
| Jan. 2, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | F | Common Stock, par value $0.001 per share | 10600 | $0.00 | 267,338.0000 | 124,943,603 | 3.81% | 0.01% |
| Jan. 2, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | M | Common Stock, par value $0.001 per share | 42105 | $0.00 | 277,938.0000 | 124,943,603 | 17.85% | 0.03% |
| Jan. 2, 2025 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | M | Restricted Stock Units | 42105 | $0.00 | 2,238,753.0000 | 124,943,603 | 1.85% | 0.03% |
| Dec. 27, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | M | Restricted Stock Units | 1333 | $0.00 | 2,280,858.0000 | 125,407,279 | 0.06% | 0.00% |
| Dec. 27, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | M | Common Stock, par value $0.001 per share | 1333 | $0.00 | 236,157.0000 | 125,407,279 | 0.57% | 0.00% |
| Dec. 27, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | F | Common Stock, par value $0.001 per share | 324 | $0.00 | 235,833.0000 | 125,407,279 | 0.14% | 0.00% |
| Nov. 21, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | A | Options to purchase common stock | 491160 | $0.00 | 2,222,172.0000 | 125,407,279 | 28.37% | 0.39% |
| Nov. 21, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | A | Restricted Stock Units | 60019 | $0.00 | 2,282,191.0000 | 125,407,279 | 2.70% | 0.05% |
| June 4, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | M | Options to purchase common stock | 40000 | $0.00 | 1,731,012.0000 | 113,753,154 | 2.26% | 0.04% |
| June 4, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | M | Common stock, par value $0.001 per share | 40000 | $4.01 | 252,147.0000 | 113,753,154 | 18.85% | 0.04% |
| June 4, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | S | Common stock, par value $0.001 per share | 17323 | $15.98 | 234,824.0000 | 113,753,154 | 6.87% | 0.02% |
| Feb. 15, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | M | Common stock, par value $0.001 per share | 4000 | $0.00 | 213,333.0000 | 113,753,154 | 1.91% | 0.00% |
| Feb. 15, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | F | Common stock, par value $0.001 per share | 1186 | $0.00 | 212,147.0000 | 113,753,154 | 0.56% | 0.00% |
| Feb. 15, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | A | Restricted Stock Units | 4000 | $0.00 | 1,771,012.0000 | 113,753,154 | 0.23% | 0.00% |
| Jan. 1, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | A | Options to purchase common stock | 1365319 | $0.00 | 1,564,486.0000 | 113,753,154 | 685.51% | 1.20% |
| Jan. 1, 2024 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | President and CEO | A | Restricted Stock Units | 210526 | $0.00 | 1,775,012.0000 | 113,753,154 | 13.46% | 0.19% |
| Dec. 27, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | Director | M | Restricted Stock Units | 1333 | $0.00 | 199,167.0000 | 111,375,631 | 0.66% | 0.00% |
| Dec. 27, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | Director | M | Common Stock, par value $0.001 per share | 1333 | $0.00 | 209,333.0000 | 111,375,631 | 0.64% | 0.00% |
| Dec. 7, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | Director | M | Options to purchase common stock | 60000 | $0.00 | 200,500.0000 | 111,375,631 | 23.03% | 0.05% |
| Dec. 7, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | Director | M | Common Stock, par value $0.001 per share | 60000 | $1.13 | 208,000.0000 | 111,375,631 | 40.54% | 0.05% |
| May 12, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | Director | M | Options to purchase common stock | 50000 | $0.00 | 260,500.0000 | 111,375,631 | 16.10% | 0.04% |
| May 12, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | Director | M | Common Stock, par value $0.001 per share | 50000 | $0.79 | 148,000.0000 | 111,375,631 | 51.02% | 0.04% |
| Feb. 15, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | Director | M | Common Stock, par value $0.001 per share | 4000 | $0.00 | 98,000.0000 | 111,375,631 | 4.26% | 0.00% |
| Feb. 15, 2023 | CATALYST PHARMACEUTICALS, INC. | $CPRX | Daly Richard J | Director | M | Restricted Stock Units | 4000 | $0.00 | 310,500.0000 | 111,375,631 | 1.27% | 0.00% |